TMH Spotlight: Iceni Gold (ASX:ICL) discovers further gold at Guyer target area, Telix Pharmaceuticals (ASX:TLX) doses first patient in phase two cancer study


The ASX was trading positively at midday, up almost 0.7 per cent.

Most sectors secured gains, with healthcare leading the pack, up nearly two per cent at midday.

In ASX news, Iceni Gold (ICL) has made further gold finds along the 15-kilometre-long trend at its Guyer target area in Western Australia.

The company recently discovered a nearly 1.5-ounce gold nugget, which it believes further supports the prospectivity of Guyer North. ICL was last trading at 11 cents.

Telix Pharmaceuticals (TLX) has dosed the first patient for its phase II study treating a broad range of cancers.

The company’s Starburst study is designed to investigate its treatment for patients suffering from a diverse range of solid cancerous tumours, including breast, cervix colorectal, lung and ovarian cancers. TLX shares were up 0.26 per cent, last trading at $11.44 a share.

Hillgrove Resources (HGO) has decided to proceed with the stage one development of its Kanmantoo underground copper mine in South Australia.

The company’s underground development of the site started in May in anticipation of a positive investment decision. The company’s shares were last trading at 5.7 cents a share.

Lithium Power International (LPI) has entered an agreement with Albemarle Lithium to sell its Australian subsidiary Western Lithium for $30 million.

LPI’s CEO said this deal will add significant cash to the company’s balance sheet. LPI shares last traded at 32 cents.


arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.